Fairman Group »

Biogen Idec shares owned by Fairman Group

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Fairman Group from 13F filings

Historical chart of Fairman Group investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Fairman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Fairman Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3k 6 215.67
2023-12-31 $1.6k 6 258.83

More positions owned by Fairman Group

Accenture Plc Ireland Shs Class A (ACN)
Ishares Tr Core S&p500 Etf (IVV)
Accolade (ACCD)
Essent (ESNT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
W.R. Berkley Corporation (WRB)
Veeva Sys Cl A Com (VEEV)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Eafe Etf (EFA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)

View all positions for Fairman Group

Top funds holding Biogen Idec

PRIMECAP Management Company
Vanguard Group
Wellington Management Company
Jpmorgan Chase & Co
Van Eck Associates Corp.
ClearBridge Advisors
Legal & General Group
T. Rowe Price Associates
Norges Bank Investment Management
Dimensional Fund Advisors
Bank of New York Mellon
Amundi
Deutsche Bank Aktiengesellschaft
Susquehanna International
Goldman Sachs Group

View all funds holding Biogen Idec